Silence Therapeutics plc (SLN)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 09:55AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.12B |
| Enterprise value | 1.05B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 26.55 |
| Price/book (mrq) | 49.67 |
| Enterprise value/revenue | 41.47 |
| Enterprise value/EBITDA | -21.14 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.40 |
| 52-week change 3 | 359.39% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 27.72 |
| 52-week low 3 | 4.60 |
| 50-day moving average 3 | 23.06 |
| 200-day moving average 3 | 14.22 |
Share statistics
| Avg vol (3-month) 3 | 234.2k |
| Avg vol (10-day) 3 | 189.06k |
| Shares outstanding 5 | 46.62M |
| Implied shares outstanding 6 | 36.75M |
| Float 8 | 72.94M |
| % held by insiders 1 | 17.00% |
| % held by institutions 1 | 45.88% |
| Shares short (28 Mar 2024) 4 | 92.66k |
| Short ratio (28 Mar 2024) 4 | 0.67 |
| Short % of float (28 Mar 2024) 4 | N/A |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.35% |
| Shares short (prior month 29 Feb 2024) 4 | 46.2k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -170.51% |
| Operating margin (ttm) | -633.59% |
Management effectiveness
| Return on assets (ttm) | -30.80% |
| Return on equity (ttm) | -221.19% |
Income statement
| Revenue (ttm) | 25.38M |
| Revenue per share (ttm) | 0.68 |
| Quarterly revenue growth (yoy) | -56.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -49.27M |
| Net income avi to common (ttm) | -43.27M |
| Diluted EPS (ttm) | -1.44 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 54.03M |
| Total cash per share (mrq) | 0.39 |
| Total debt (mrq) | 272k |
| Total debt/equity (mrq) | 1.59% |
| Current ratio (mrq) | 4.56 |
| Book value per share (mrq) | 0.43 |
Cash flow statement
| Operating cash flow (ttm) | -39.35M |
| Levered free cash flow (ttm) | -22.88M |
© 2024 Yahoo. All rights reserved.